PROJET AUTOBLOG


Richard Stallman's Political Notes

Site original : Richard Stallman's Political Notes

⇐ retour index

Worst argument for leaving the EU

mercredi 1 juin 2016 à 02:00

The worst possible argument for talking Britain out of the EU: reducing tax on heating oil.

It would be easy for the state to help poor people cope with these costs: increase welfare benefits for the poor, to an extent that covers what the poor pay in VAT on oil. (Or even more, why not?) For the poor, this would be equivalent; meanwhile, the wealthier would still pay the tax, and the poor would still have an incentive to use less fossil fuel.

The idea of cutting taxes on fossil fuels, instead of cutting their subsidies, reflects a planet roaster.

Urgent: GMO Food labelling

mercredi 1 juin 2016 à 02:00

Citizens of Massachusetts: call on the legislator to vote on GMO Food labelling bill and pass it.

With Javascript disabled, the signing process won't work all the way through automatically. Instead, it will terminate showing you a long URL with [URL] in place of the domain name.

If you replace [URL] with http://salsa3.salsalabs.com, and visit the resulting URL, that will finish signing.

Urgent: Reject China's future puppet

mercredi 1 juin 2016 à 02:00

US citizens: call on everyone to reject China's future puppet Dalai Lama.

Urgent: Block attack on Net Neutrality

mercredi 1 juin 2016 à 02:00

US citizens: call on your congresscritter to block the sneak attack on Net Neutrality.

Colombia threatened about cancer drug

mardi 31 mai 2016 à 02:00

The US Trade Representative threatened Colombia with cuts in support for peace with the guerrillas if it went ahead with licensing generic versions of a cancer drug.

If not for the murderous World Trade Organization, Colombia could simply legislate that there are no patents on medicines.

Here is more information about this issue.

It is disappointing that KEI uses the spin term "protection" to describe what patents do. There is no reason to use that word except propaganda for the drug companies.